Loading clinical trials...
Loading clinical trials...
A Prospective and Retrospective Registry and Biomarker Study to Evaluate the Natural History of Pediatric Patients With Cardiomyopathy Due to MYBPC3 Mutations
Conditions
Locations
29
United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
University of California Davis Health
Sacramento, California, United States
Rady Children's Hospital - San Diego
San Diego, California, United States
University of Colorado Hospital - Anschutz Medical Campus
Aurora, Colorado, United States
Nemours Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States
Start Date
November 1, 2021
Primary Completion Date
June 1, 2028
Completion Date
June 1, 2028
Last Updated
November 13, 2024
NCT01143454
NCT07207811
NCT05836259
NCT07054073
NCT07344480
NCT07052903
Lead Sponsor
Tenaya Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions